Show simple item record

dc.contributor.authorHalling-Brown, MD
dc.contributor.authorBulusu, KC
dc.contributor.authorPatel, M
dc.contributor.authorTym, JE
dc.contributor.authorAl-Lazikani, B
dc.date.accessioned2018-06-28T14:43:45Z
dc.date.issued2012-01-01
dc.identifier.citationNucleic acids research, 2012, 40 (Database issue), pp. D947 - D956
dc.identifier.issn0305-1048
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1967
dc.identifier.eissn1362-4962
dc.identifier.doi10.1093/nar/gkr881
dc.description.abstractcanSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify biological annotation of a target, its structural characterization, expression levels and protein interaction data, as well as suitable cell lines for experiments, potential tool compounds and similarity to known drug targets. canSAR has, from the outset, been completely use-case driven which has dramatically influenced the design of the back-end and the functionality provided through the interfaces. The Web interface at http://cansar.icr.ac.uk provides flexible, multipoint entry into canSAR. This allows easy access to the multidisciplinary data within, including target and compound synopses, bioactivity views and expert tools for chemogenomic, expression and protein interaction network data.
dc.formatPrint-Electronic
dc.format.extentD947 - D956
dc.languageeng
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectCell Line, Tumor
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectAntineoplastic Agents
dc.subjectGene Expression
dc.subjectRNA Interference
dc.subjectModels, Molecular
dc.subjectSystems Integration
dc.subjectInternet
dc.subjectDatabases, Genetic
dc.subjectGenetic Variation
dc.subjectDrug Discovery
dc.subjectTranslational Medical Research
dc.subjectProtein Interaction Maps
dc.titlecanSAR: an integrated cancer public translational research and drug discovery resource.
dc.typeJournal Article
rioxxterms.versionofrecord10.1093/nar/gkr881
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc/4.0
rioxxterms.licenseref.startdate2012-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNucleic acids research
pubs.issueDatabase issue
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Computational Biology and Chemogenomics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Computational Biology and Chemogenomics
pubs.publication-statusPublished
pubs.volume40
pubs.embargo.termsNot known
icr.researchteamComputational Biology and Chemogenomics
dc.contributor.icrauthorAl-Lazikani, Bissan


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0